The nominations period has closed. Voting will open September 11.

Ten biotechs will be nominated in each of the three categories, "Early Stage Entrepreneurs", "Late Stage Leaders" and "Diagnostics and Beyond". 

• To qualify for the Early Stage Entrepreneur Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised less than $25 million USD as of July 1, 2018; have been founded after 2015; and have most recently completed either a Seed or Series A financing round. Companies that have previously presented at the BIO Investor Forum are not eligible for the Early Stage Entrepreneur category but are welcome to apply under the Late Stage Leader category (if the company meets the minimum dollar requirements of the Late Stage Leader category).

• To qualify for the Late Stage Leader Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised more than $25 million USD as of July 1, 2018 and have enrolled at least one patient in a company-sponsored clinical trial posted at https://clinicaltrials.gov/. 

• To qualify for the Diagnostics and Beyond category, companies must be primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies. 

Please note that the contest is open to U.S. companies only.

Read the official contest rules here. This page displays best on Chrome browsers.